EP2082771A1 — Inhaler
Assigned to Vectura Delivery Devices Ltd · Expires 2009-07-29 · 17y expired
What this patent protects
An inhaler (10) is disclosed. It comprises a housing (12) to receive a strip (3) having a plurality of blisters (3a), each blister having a breachable lid and containing a dose of medicament for inhalation by a user, an indexing wheel (15) mounted in the housing rotatable to driv…
USPTO Abstract
An inhaler (10) is disclosed. It comprises a housing (12) to receive a strip (3) having a plurality of blisters (3a), each blister having a breachable lid and containing a dose of medicament for inhalation by a user, an indexing wheel (15) mounted in the housing rotatable to drive a strip to sequentially move blisters into alignment with a blister piercing member (8), a control element (14) pivotally mounted to the housing and a drive mechanism (17) configured to couple the control element to the indexing wheel during part of the rotation of the control element by a user so that the indexing wheel rotates together with the control element.
Drugs covered by this patent
- Arnuity Ellipta (FLUTICASONE FUROATE) · Haleon Us Holdings
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.